Anthranilic acid derivatives
AssigneeEisai Co., Ltd.
InventorsFumihiro Ozaki, Keiji Ishibashi, Hironori Ikuta, Hiroki Ishihara, Shigeru Souda
Life of this patent
Estimating the term…
Loading patent…
AssigneeEisai Co., Ltd.
InventorsFumihiro Ozaki, Keiji Ishibashi, Hironori Ikuta, Hiroki Ishihara, Shigeru Souda
Estimating the term…
The present invention provides an anthranilic acid derivative having a cGMP-PDE inhibitory activity. An anthranilic acid derivative represented by the general formula (I) or a pharmacologically acceptable salt thereof: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 represent the same or different from each other, a hydrogen atom, a halogen atom, a hydroxy group, an optionally halogenated lower alkyl group, an optionally halogenated lower alkoxy group, a nitro group, a hydroxyalkyl group, a cyano group or the like; R.sup.5 and R.sup.6 represent the same or different from each other, a hydrogen atom, a halogen atom, a hydroxy group, a cyano group, an optionally halogenated lower alkyl group, an optionally halogenated lower alkoxy group or the like; W represents a group of the formula: --N.dbd. or --CH.dbd.; R.sup.7 and R.sup.8 represent the same or different from each other, a hydrogen atom, an optionally halogenated lower alkyl group or the like; A represents a hydrogen atom, an optionally halogenated lower alkyl group or the like; Y represents an oxygen atom or a sulfur atom; and n is an integer of 0 to 6!.
An anthranilic acid derivative represented by the general formula (I) or a pharmacologically acceptable salt thereof:
Dependencies are inferred from the claim text.